Skip to main content
. 2019 Feb 6;6(3):e154–e166. doi: 10.1016/S2352-3026(18)30220-5

Figure 2.

Figure 2

Kaplan-Meier curves for overall survival and progression-free survival across the MRP groups

(A) Overall survival in the training population, NCRI Myeloma XI (NCRI-XI; n=1852). (B) Overall survival in the test population, MRC Myeloma IX (MRC-IX; n=520). (C) Progression-free survival in NCRI-XI (n=1852). (D) Progression-free survival in MRC-IX (n=520). MRP=UK Myeloma Research Alliance Risk Profile.